FDA Recalls Finder

FDA Commissioner announces Avastin decision
18 November 2011, 9:31 am

FDA Commissioner Margaret A. Hamburg, M.D., said today she is revoking the agency’s approval of the breast cancer indication for Avastin (bevacizumab) after concluding that the drug has not been shown to be safe and effective for that use.

Source: Food and Drug Administration--Press Releases